Patricia Alfonso
Co-founder, Chief Scientific Officer
Pharma
Enzymlogic
Spain
Biography
Patricia has devoted nearly 20 years to biomedical research at leading academic institutions such as the Spanish National Cancer Research Center (CNIO), the National Center for Biotechnology and the NYU Langone Medical Center.She has extensive experience in enzymology and proteomics applied to drug discovery. At CNIO, she focused on the mechanistic and kinetic aspects of protein-ligand interactions for exploitation in drug design, and participated in the development of a wide range of kinase inhibitors. This work lead to the discovery of several Pan-Pim and dual PI3K-PIM inhibitors recently licensed to Inflection Biosciences Ltd. Patricia has also participated in the discovery of diagnostic and prognostic markers for lung and colon cancer.She obtained her degree in Chemistry from the Complutense University and gained her PhD in Biochemistry from the Autonomous University. Currently, she is Professor in Drug Design at the Francisco de Victoria University.
Research Interest
enzymology and proteomics applied to drug discovery.
